Physician profile
Brandon J Smith
NPI 1003243213
$108,369.26
in general payments reported to CMS, 2019-2025
9 companies · $36K in 2025
The $36K reported for 2025 was more than what 97% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $15K · 2023: $19K · 2024: $38K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $42K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Travel and Lodging: $9,278 · Food and Beverage: $4,472 · Consulting Fee: $3,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $42,005.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33,746.25 |
| Travel and Lodging | $9,277.91 |
| Food and Beverage | $4,471.92 |
| Consulting Fee | $3,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $57,703.41 | 2021-2025 | Fetroja |
| Melinta Therapeutics, LLC | $37,733.85 | 2021-2025 | Rezzayo, Vabomere |
| Abbvie INC. | $12,297.49 | 2022-2025 | |
| Angiodynamics, INC. | $220.10 | 2024 | Angiovac |
| Paratek Pharmaceuticals, INC. | $121.23 | 2022-2023 | Nuzyra |
| Aimmune Therapeutics, INC. | $120.49 | 2023 | |
| Insmed, INC. | $90.35 | 2022 | |
| Janssen Products, Lp | $53.09 | 2022 | |
| Abbott Laboratories | $29.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.